We are live on ! Find out more
Longview Partners

Longview Partners Portfolio holdings

AUM $6.16B Turnover 15.38%
1-Year Est. Return 3.55%
 

Longview Partners is a specialist global equity manager that holds a concentrated portfolio of world stocks, using the same philosophy since it started in 2001. It looks for high-quality businesses that can build value steadily over time, wants a margin of safety on price, and relies on picking individual stocks rather than steering the overall portfolio. Its clients are institutions, and Northill Capital is its majority shareholder.

This Fund
S&P 500
This Quarter Est. Return
+4.49%
1 Year Est. Return
+3.55%
3 Year Est. Return
+35.76%
5 Year Est. Return
+55.83%
10 Year Est. Return
+255.17%
AUM
$18.5B
AUM Growth
+$1.17B
Cap. Flow
+$442M
Cap. Flow %
2.39%
Top 10 Hldgs %
50.51%
Holding
28
New
–
Increased
22
Reduced
3
Closed
3
Avg Time Held
2.7 years
Top 10 Avg Time Held
1 year
Top 20 Avg Time Held
2.3 years

Top Buys

Rank Stock Value
1
DG icon
Dollar General
DG
+$248M
2
GWW icon
W.W. Grainger
GWW
+$210M
3
PFE icon
Pfizer
PFE
+$200M
4
WFC icon
Wells Fargo
WFC
+$191M
5
HCA icon
HCA Healthcare
HCA
+$165M

Top Sells

Rank Stock Value
1
ACN icon
Accenture
ACN
+$637M
2
PGR icon
Progressive
PGR
+$629M
3
AVT icon
Avnet
AVT
+$161M
4
MD icon
Pediatrix Medical
MD
+$120M
5
TEL icon
TE Connectivity
TEL
+$63.3M

Sector Composition

Rank Sector Weight
1 Healthcare 29.21%
2 Financials 26.3%
3 Industrials 17.04%
4 Technology 14.8%
5 Consumer Discretionary 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
AON icon
1
Aon
AON
$71.7B
$1.02B 5.53%
7,001,377
+301,300
+4% +$42M
2013 Q2
17 quarters
APTV icon
2
Aptiv
APTV
$8.86B
$1B 5.43%
10,211,866
+439,200
+4% +$41.4M
2013 Q2
17 quarters
PH icon
3
Parker-Hannifin
PH
$119B
$947M 5.12%
5,413,458
+278,500
+5% +$45.7M
2015 Q2
9 quarters
FIS icon
4
Fidelity National Information Services
FIS
$16.5B
$936M 5.06%
10,025,942
+521,300
+5% +$47.4M
2013 Q2
17 quarters
UNH icon
5
UnitedHealth
UNH
$355B
$925M 5%
4,724,845
+214,300
+5% +$41.4M
2014 Q1
14 quarters
BNY icon
6
Bank of New York Mellon
BNY
$102B
$922M 4.98%
17,381,984
+862,800
+5% +$45.3M
2013 Q2
17 quarters
DG icon
7
Dollar General
DG
$30.2B
$918M 4.96%
11,321,660
+3,310,168
+41% +$248M
2017 Q2
1 quarter
GWW icon
8
W.W. Grainger
GWW
$71.4B
$899M 4.86%
5,001,477
+1,245,771
+33% +$210M
2015 Q4
7 quarters
WFC icon
9
Wells Fargo
WFC
$264B
$890M 4.81%
16,146,737
+3,602,070
+29% +$191M
2013 Q2
17 quarters
HCA icon
10
HCA Healthcare
HCA
$104B
$886M 4.79%
11,135,155
+2,053,701
+23% +$165M
2013 Q3
16 quarters
ZBH icon
11
Zimmer Biomet
ZBH
$20.8B
$879M 4.75%
7,731,885
+1,162,843
+18% +$134M
2015 Q3
8 quarters
IQV icon
12
IQVIA
IQV
$43.9B
$876M 4.73%
9,218,227
+506,780
+6% +$47M
2016 Q4
3 quarters
WTW icon
13
Willis Towers Watson
WTW
$30.9B
$876M 4.73%
5,677,694
+355,228
+7% +$53M
2016 Q2
5 quarters
ORCL icon
14
Oracle
ORCL
$381B
$872M 4.71%
18,030,571
+1,783,200
+11% +$88.7M
2013 Q2
17 quarters
PFE icon
15
Pfizer
PFE
$174B
$870M 4.7%
25,685,634
+6,219,759
+32% +$200M
2013 Q2
17 quarters
EMR icon
16
Emerson Electric
EMR
$94.9B
$865M 4.67%
13,758,325
+1,134,275
+9% +$68.4M
2015 Q1
10 quarters
TMO icon
17
Thermo Fisher Scientific
TMO
$262B
$864M 4.67%
4,564,913
+313,782
+7% +$56.8M
2015 Q3
8 quarters
STT icon
18
State Street
STT
$47.1B
$770M 4.16%
8,062,726
+493,244
+7% +$45.9M
2017 Q1
2 quarters
FISV icon
19
Fiserv Inc
FISV
$32.4B
$695M 3.76%
10,783,038
+2,040,242
+23% +$127M
2013 Q2
17 quarters
TMX
20
DELISTED
Terminix Global Holdings, Inc.
TMX
$444M 2.4%
14,170,035
+623,749
+5% +$18.4M
2016 Q2
5 quarters
OMC icon
21
Omnicom Group
OMC
$23.8B
$419M 2.26%
5,653,698
+1,653,208
+41% +$127M
2014 Q1
14 quarters
PGR icon
22
Progressive
PGR
$135B
$296M 1.6%
6,106,851
-13,440,167
-69% -$629M
2015 Q1
10 quarters
ARW icon
23
Arrow Electronics
ARW
$10.5B
$236M 1.28%
2,936,104
+143,540
+5% +$11.3M
2013 Q2
17 quarters
MD icon
24
Pediatrix Medical
MD
$2.46B
$107M 0.58%
2,491,731
-2,531,745
-50% -$120M
2016 Q4
3 quarters
AXP icon
25
American Express
AXP
$225B
$93.1M 0.5%
1,028,945
-41,170
-4% -$3.54M
2016 Q4
3 quarters
1
2

Similar funds

Samlyn Capital
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
Milford Funds
Milford Funds Auckland $6.14B AUM
Sumitomo Life Insurance
Sumitomo Life Insurance Tokyo, Japan $6.12B AUM 21.82% 1-Year Est. Return
Mizuho Securities USA
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
EQF
Evergreen Quality Fund Grand Cayman, Cayman Islands $6.2B AUM 288.56% 1-Year Est. Return
Diversified Trust
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Alpha Wave Global
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Longview Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Longview Partners held 28 positions worth $18.5B, up 6.8% from $17.3B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Longview Partners's Q3 2017 filing shows 22 increased, 3 reduced and 3 closed positions. The largest sale was Accenture, an estimated $637M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 28% a quarter earlier, followed by Financials and Industrials.

  • Longview Partners added most to Dollar General in Q3 2017, an estimated $248M increase.
  • Longview Partners's biggest Q3 2017 reduction was Progressive, cutting an estimated $629M.
  • Longview Partners fully exited Accenture in Q3 2017, selling an estimated $637M.
  • Longview Partners's ten largest holdings make up 51% of its $18.5B portfolio in Q3 2017.
  • Longview Partners opened 0 new positions and closed 3 in Q3 2017.
  • Longview Partners's portfolio value rose 6.8% quarter-over-quarter to $18.5B.

Based on Longview Partners's 13F filing for Q3 2017, filed 30 Oct 2017.